Xtalks Life Science Podcast
By Xtalks
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by Xtalks
Category: Life Sciences
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 3
Reviews: 0
Episodes: 258
Description
This Life Science focused podcast brings together Xtalks editorial staff to share insights into the latest B2B industry news. Xtalks connects professionals in the life science, medical device, and food industries with useful content like webinars, job opening, articles and virtual meetings.
| Episode | Date |
|---|---|
|
Why Endometriosis Needs New Treatment Approaches with EndoCyclic Therapeutics’ Dr. Tanya Petrossian
|
Jul 08, 2026 |
|
Precision Oncology in Lung Cancer with Boehringer Ingelheim’s Itziar Canamasas and Volker Teichgräber
|
Jun 24, 2026 |
|
Sustainability in Asthma and COPD Drug Development with Chiesi’s Diego Ardigò
|
Jun 10, 2026 |
|
What’s Next in Cardiometabolic Disease Drug Development: Obesity, MASH and Beyond with MetaVia’s Hyung Heon Kim
|
Jun 04, 2026 |
|
How Real-World Evidence Is Shaping Inclusive Clinical Trials with Takeda CMO Dr. Awny Farajallah
|
May 27, 2026 |
|
Stem Cell Therapies for Degenerative Disc Disease and More with BioRestorative’s Lance Alstodt
|
May 20, 2026 |
|
New Blood Test for Early Alzheimer’s Detection with FNIH’s Dr. Alessio Travaglia
|
May 13, 2026 |
|
Targeting Ischemic Disease with DiaMedica CEO Rick Pauls
|
May 06, 2026 |
|
Why Copyright Matters in Life Sciences in the Age of AI: Featuring Neal Dunkinson of Copyright Clearance Center
|
Apr 29, 2026 |
|
Neuromodulation and Nerve Ablation for Chronic Pain with NeuroOne CEO Dave Rosa
|
Apr 22, 2026 |
|
Off the Shelf Cell Therapies for Bone Marrow Transplantation with Ossium Health’s Kevin Caldwell
|
Apr 15, 2026 |
|
Scalable Biologics Production Trends: Featuring Omar Wahab of Lonza
|
Apr 08, 2026 |
|
Novel Therapeutic and Trial Approaches for Lysosomal Storage Disorders with Polaryx’s Alex Yang
|
Apr 01, 2026 |
|
Psilocybin Treatments for Treatment-Resistant Depression with Compass Pathways’ Dr. Steve Levine
|
Mar 25, 2026 |
|
First Surrogate Endpoint in Osteoporosis Drug Trials with FNIH’s Dr. Tania Kamphaus
|
Mar 18, 2026 |
|
From Insights to Impact: Rare Disease Therapies with UCB’s Dr. Kim Moran
|
Mar 11, 2026 |
|
Rare Disease Day Insight: Epilepsy Care Gaps in Pregnancy with UCB’s Andrea Wilkinson
|
Mar 04, 2026 |
|
Anti-Aging Gene Therapy in Alzheimer’s and ALS with Klotho Neurosciences’ Dr. Joseph Sinkule
|
Feb 18, 2026 |
|
Translating Nerve Growth Factor Biology into Ocular Disease Therapies with Dompé’s Dr. Ahmed Enayetallah
|
Feb 04, 2026 |
|
Innovative Approaches to Regenerative Therapies in Wound Care with BioStem CEO Jason Matuszewski
|
Jan 28, 2026 |
|
Fostering Collaboration to Accelerate Drug Discovery with the Chicago Biomedical Consortium’s (CBC) Dr. Michelle Hoffmann
|
Jan 27, 2026 |
|
How Public-Private Partnerships Are Advancing Biomedical Research with FNIH’s Dr. Stacey Adam
|
Jan 14, 2026 |
|
Targeting Inflammation in Eye Diseases with Iolyx Therapeutics’ CEO Elizabeth Jeffords
|
Jan 07, 2026 |
|
Pioneering Biosensors for Continuous Medical Monitoring with Profusa CEO Dr. Ben Hwang
|
Dec 10, 2025 |
|
The Biology of Aging: Innovations in Cellular Rejuvenation with Life Biosciences’ Dr. Sharon Rosenzweig-Lipson
|
Dec 03, 2025 |
|
The Evolving Landscape of Respiratory and Immunology Drug Development with AstraZeneca’s Dr. Andrew Menzies-Gow
|
Nov 26, 2025 |
|
Restoring Lost Synapses in ALS, Fragile X and More with Spinogenix’s Dr. Peter Vanderklish
|
Nov 19, 2025 |
|
Targeting Protein Misfolding and Innovations in Hepatobiliary Disease with Rectify Pharma’s Dr. Pol Boudes
|
Nov 11, 2025 |
|
Advancing Rare Disease Treatment and Care with Takeda’s Dr. Mike Denne
|
Nov 05, 2025 |
|
Advancing Innovations for Diabetes and Cardiovascular Disease with Lexicon Pharmaceuticals’ CEO Mike Exton
|
Oct 29, 2025 |
|
At the Heart of Gene Therapy: Lexeo’s R. Nolan Townsend on Genetic Medicines for Cardiovascular Diseases and More
|
Oct 22, 2025 |
|
Teaching the Pancreas to Heal Itself: Dr. Juan Domínguez-Bendala on Regenerative Diabetes Research
|
Oct 15, 2025 |
|
From Lab to Launch: Spinning out Biotech Innovation with RBL’s Dr. Paul Wotton
|
Oct 08, 2025 |
|
Exploring the Future of Cannabinoid & Psychedelic Therapies with Joel Latham of Incannex Healthcare
|
Sep 30, 2025 |
|
Driving Innovation in Oncology: Insights from Jeff Glazier of General Oncology
|
Sep 24, 2025 |
|
The Next Generation of Cell Therapy with Cartherics’ COO Dr. Ian Nisbet
|
Sep 17, 2025 |
|
Why MASH Matters: The Next Steps in Liver Disease Innovation with 89bio’s Rohan Palekar
|
Sep 10, 2025 |
|
Bridging Aesthetics and Therapeutics in Dermatology with Galderma’s Dr. Bill Andriopoulos
|
Sep 03, 2025 |
|
The Neuroscience of Weight Regulation with Courage Therapeutics’ Dr. Roger Cone
|
Aug 27, 2025 |
|
Exploring Immunomodulation Without Immunosuppression with Artax Biopharma’s Dr. Rob Armstrong
|
Aug 19, 2025 |
|
Advancing Neurotherapeutics for Fragile X and Beyond with Spinogenix CMO Dr. Craig Erickson
|
Aug 13, 2025 |
|
Driving Neuro Innovation with Neurizon Therapeutics CEO Dr. Michael Thurn
|
Aug 06, 2025 |
|
Restoring Synapses to Fight ALS, Alzheimer’s and More with Spinogenix CEO Dr. Stella Sarraf
|
Jul 30, 2025 |
|
Championing the Patient Voice with Ardelyx’s Chief Patient Officer Dr. Laura Williams
|
Jul 23, 2025 |
|
Inside AI-Powered Drug Discovery with Gain Therapeutics’ CEO Gene Mack
|
Jul 16, 2025 |
|
Targeting Mast Cells: A New Frontier in Allergy & Inflammation with Jasper Therapeutics’ CMO Dr. Edwin Tucker
|
Jul 09, 2025 |
|
Reprogramming Cancer: A New Era of AI-Powered Immunotherapy with CancerVax’s Adam Grant
|
Jul 02, 2025 |
|
Understanding Desmoid Tumors: Insights from Dr. Alessandra Maleddu, Sarcoma Specialist at University of Colorado
|
Jun 25, 2025 |
|
Advancing Dendritic Cell Immunotherapy for Glioblastoma: Insights from Diakonos Oncology’s Jay Hartenbach
|
Jun 18, 2025 |
|
Pioneering A New Era of T-Cell Immunotherapy with CERo Therapeutics’ CEO Chris Ehrlich
|
Jun 11, 2025 |
|
Radiopharmaceuticals and the Future of Nuclear Medicine with RadioMedix CEO Dr. Ebrahim Delpassand
|
May 21, 2025 |
|
Building the Future of Brain Health: Neuroscience Drug Development with Novartis’ Dr. Norman Putzki
|
May 14, 2025 |
|
Rare Disease Innovation in an Evolving Industry with Amgen’s Dr. Sumita Bhatta
|
May 07, 2025 |
|
Advancing Novel Immunotherapy Approaches for Osteosarcoma and Beyond with Paul Romness, CEO of OS Therapies
|
Apr 30, 2025 |
|
Targeting the Cell’s Powerhouse: Dr. Shaharyar Khan on Rivus Pharma’s Mitochondrial Approach to Cardiometabolic Diseases
|
Apr 23, 2025 |
|
Inside the Latest in Targeted Radiotherapeutics with Plus Therapeutics CEO Dr. Marc Hedrick
|
Apr 16, 2025 |
|
From Lab to Launch: Commercializing Gene Therapies for Rare Diseases with Rocket Pharma’s Carlos Martin
|
Apr 09, 2025 |
|
Combating Autoimmunity: Vera Therapeutics CEO Dr. Marshall Fordyce Discusses Advancing IgAN Treatments
|
Apr 02, 2025 |
|
Targeting Pressing Unmet Needs in Kidney Diseases with Unicycive Therapeutics CEO Dr. Shalabh Gupta
|
Mar 26, 2025 |
|
Innovating Treg Therapies for ALS and Alzheimer’s with Coya Therapeutics CEO Dr. Arun Swaminathan
|
Mar 19, 2025 |
|
The Path to Healthy Aging: Pioneering Therapies for Age-Related Diseases with Rejuvenate Biomed's Ann Beliën
|
Mar 12, 2025 |
|
Driving Innovations in Rare Diseases with Takeda’s Anthea Cherednichenko
|
Feb 26, 2025 |
|
Advancing Alzheimer’s Diagnostics: Insights from ALZpath VP of R&D Dr. Lee Honigberg on the Future of Blood-Based Biomarker Assays
|
Feb 19, 2025 |
|
Advancing PTSD Treatment with Digital Brain Biomarkers ft. Oded Kraft, Co-Founder, CEO and President of GrayMatters Health
|
Feb 12, 2025 |
|
Innovating Immune-Modulating Therapies in Autoimmune Disorders ft. Dr. Mario Marcondes, VP Head of Clinical Development, Nektar Therapeutics
|
Feb 05, 2025 |
|
Advancing Digital Approaches in Alzheimer’s Research and Care ft. Sarah Averill Lott, Research Lead, Digital Medicine Society (DiMe) & Diane Stephenson, Executive Director, Critical Path for Parkinson
|
Jan 29, 2025 |
|
Transformative Neuropsychiatric Therapies ft. Dr. Amit Etkin, Founder, President and CEO of Alto Neuroscience
|
Jan 22, 2025 |
|
Pioneering Cancer Treatment with Alpha Radiation Technology ft. Alpha Tau Medical CMO Dr. Robert Den
|
Jan 15, 2025 |
|
Innovations in Immunomodulators for Diseases of the Immune System ft. Dr. Judy Chou, CEO, AltruBio
|
Jan 08, 2025 |
|
Innovating Cell-Based Solutions for Type 1 Diabetes ft. Jonathan Rigby, CEO, Sernova
|
Dec 18, 2024 |
|
Immune-Based Intratumoral Cancer Therapies ft. Intensity Therapeutics founder and CEO Lewis Bender
|
Dec 12, 2024 |
|
Targeting Cancer Drug Resistance with Kairos Pharma’s CEO Dr. John Yu
|
Dec 04, 2024 |
|
Innovating Immunotherapeutics with Oncolytic Virus Therapy ft. Oncolytics Biotech’s CMO Dr. Thomas Heineman
|
Nov 27, 2024 |
|
Laser Vision: Pioneering Laser Innovations for Presbyopia ft. Ace Vision’s Dr. AnneMarie Hipsley
|
Nov 20, 2024 |
|
Bringing the Tech Revolution to Medicine with Digital Therapeutics ft. Click Therapeutics’ CMO Dr. Shaheen Lakhan
|
Nov 13, 2024 |
|
Inside the Latest Advances in Hearing Tech ft. Envoy Medical CEO Brent Lucas
|
Nov 06, 2024 |
|
Advances in Heart Failure Treatment ft. Dr. Robert Perkins, VP, US Medical Affairs/Renal, Bayer
|
Oct 31, 2024 |
|
Transforming Clinical Research: A Conversation with Morgan Hanger, Executive Director of CTTI
|
Oct 23, 2024 |
|
Innovative Approaches to Antiviral Drug Development
|
Oct 16, 2024 |
|
A Unique Approach to in vivo CAR T Therapy and New Advancements in the Field
|
Oct 09, 2024 |
|
The Promise of Epigenetic Therapeutics in Alcohol-Associated Hepatitis ft. DURECT President and CEO Dr. James Brown
|
Oct 02, 2024 |
|
Pioneering mRNA Therapies for Lung Diseases
|
Sep 25, 2024 |
|
Silencing Disease: Shifting Treatment Paradigms with RNAi Therapeutics ft. Alnylam’s VP Research Dr. Kirk Brown
|
Sep 18, 2024 |
|
The Science of Sleep: Unmet Needs and Treatments for Narcolepsy ft. Avadel Pharma’s Dr. Jennifer Gudeman
|
Sep 04, 2024 |
|
Non-Hormonal Innovations in Obesity and Diabetes Treatment with Aphaia Pharma’s Dr. Steffen-Sebastian Bolz
|
Aug 28, 2024 |
|
FNIH Study Shows Promise of Blood Tests for Alzheimer’s Disease, featuring Dementia Expert Dr. Schindler and FNIH Neuroscience Director Dr. Travaglia
|
Aug 21, 2024 |
|
Beyond the Beat: Dr. Matthew Martinez Discusses HCM Care in Athletes and New Camzyos Guidelines
|
Aug 14, 2024 |
|
Bridging Science and Advocacy with Lawreen Asuncion, Life Science Professional and Rare Disease Patient Advocate
|
Aug 07, 2024 |
|
Bringing Integrated Nutritional and Pharmaceutical Approaches to the Table for GI Health with Nestlé Health Science’s Moreno Perugini
|
Jul 31, 2024 |
|
Innovating Approaches to Target Diseases of Aging with Jerry McLaughlin, CEO of Life Biosciences
|
Jul 24, 2024 |
|
Golden Innovations: Nanocrystal Therapies for ALS and MS with Clene Nanomedicines’ Dr. Karen Ho
|
Jul 16, 2024 |
|
From Symptoms to Solutions: Transforming Menopause Treatment with Marci English of Astellas Pharma
|
Jul 10, 2024 |
|
New Frontiers in MASH and Chronic Liver Diseases with Aligos CEO Dr. Lawrence Blatt
|
Jul 03, 2024 |
|
FNIH’s Dr. Travaglia and ALS Patient Advocate Dr. Sethi Discuss New ALS Program
|
Jun 26, 2024 |
|
The Road Ahead for Former ALS Hopeful Relyvrio ft. Amylyx's Joshua Cohen and Justin Klee
|
Jun 19, 2024 |
|
Insights into Precision Dosing with Dr. Howard McLeod and Dr. Sharmeen Roy
|
Jun 12, 2024 |
|
Targeting AML with a New Generation of T-Cell Therapies, ft. Brian Atwood, Chairman and CEO of CERo Therapeutics
|
Jun 05, 2024 |
|
Exploring Next-Gen Antivirals ft. Sam Lee, PhD, Co-CEO & President, Cocrystal Pharma
|
May 29, 2024 |
|
Gene Editing Innovations with Programmable Gene Insertion (PGI) Technology ft. Dr. John Finn, Tome Biosciences
|
May 22, 2024 |
|
New Frontiers in Epilepsy and Seizure Treatments ft. Dr. Jeremy Levin and Meg Alexander, Ovid Therapeutics
|
May 15, 2024 |
|
The State of Infectious Diseases and New Trivalent Flu Vaccine ft. Infectious Disease Experts Dr. William Schaffner and Dr. Kelly Moore
|
May 08, 2024 |
|
Psychedelic-Based Therapeutics for Generalized Anxiety Disorder (GAD) – Interview with Robert Barrow, CEO, MindMed
|
May 01, 2024 |
|
Developing Conditionally Active Antibodies: Interview with John K. Celebi, President & CEO, Sensei Bio.
|
Apr 24, 2024 |
|
Treg Cell Therapy for Neurodegenerative Diseases – Interview with Dr. Howard Berman, CEO, Coya Therapeutics
|
Apr 17, 2024 |
|
Improving Cancer Screening Among Métis Communities: Interview with Margaret Froh, President, Métis Nation of Ontario
|
Apr 10, 2024 |
|
Cell Therapies for Chronic Kidney Disease: Featuring Bruce Culleton, CEO, ProKidney
|
Apr 03, 2024 |
|
Tackling Diabetic Kidney Disease: Featuring Robert Perkins, VP, US Medical Affairs (Renal), Bayer
|
Mar 27, 2024 |
|
People in Life Sciences Series: Day-in-the-Life of a Pharmacovigilance Professional – Interview with Ashish Jain, Senior Director of Clinical Safety a...
|
Mar 20, 2024 |
|
Building Cancer Awareness and Empowering Métis Youth: Featuring Jordyn Playne, President, Métis Nation of Ontario Youth Council
|
Mar 13, 2024 |
|
Transforming Eye Care: Innovating New Glaucoma and Dry Eye Disease Treatments
|
Mar 06, 2024 |
|
Rare Disease Day 2024: Highlighting Patient Stories and Advancements in Rare Disease Research
|
Feb 28, 2024 |
|
Biologics Development in Immunology and Inflammation — Featuring Amir Reichman, CEO of Scinai Immunotherapeutics
|
Feb 21, 2024 |
|
Novel Approaches in Cancer Immunotherapy — Featuring OncoC4 founder, CEO and CSO Dr. Yang Liu and CFO Abid Ansari
|
Feb 14, 2024 |
|
New Targeted Treatments for Breast Cancer — Conversation with Dr. Carlos Doti, VP, US Medical Affairs Oncology, AstraZeneca
|
Feb 07, 2024 |
|
Exploring the Endocannabinoid System for Drug Development, Featuring Punit Dhillon, Chairman & CEO of Skye Bioscience
|
Jan 31, 2024 |
|
Life Science Trends for 2024
|
Jan 24, 2024 |
|
Revolutionizing Orthopedic Joint Replacement — Interview with Ben Sexson, Co-Founder, CEO, Monogram Orthopedics
|
Jan 17, 2024 |
|
Cognitive and Neuropsychiatric Disorders Drug Development, Featuring Dr. Adam Kaplin, Cofounder, President, CSO, MIRA Pharmaceuticals
|
Jan 10, 2024 |
|
Pneumococcal Vaccination for Adults: Conversation with Vaccine Scientists Dr. Heather Platt and Dr. Ulrike Buchwald from Merck
|
Dec 13, 2023 |
|
A Focus on Men’s Health — Conversation with Fady Boctor, Petros Pharma President and CCO
|
Dec 06, 2023 |
|
“Off-the-Shelf” Cellular Therapy: Interview with Longeveron CEO Wa’el Hashad
|
Nov 29, 2023 |
|
Attorney Tope Leyimu Discusses Proposed FDA ban on Hair Relaxer Products Containing Harmful Chemicals
|
Nov 22, 2023 |
|
Dr. Lahar Mehta Speaks About New Trial to Evaluate ALS Drug for Progressive Supranuclear Palsy
|
Nov 15, 2023 |
|
FDA Considers Self Administered Nasal Flu Vaccine + Wayne Gretzky Features in GSK RSV Vaccine Ad
|
Nov 08, 2023 |
|
Innovations and Clinical Trial Diversity in Medical Aesthetics: Insights from Dr. Stephanie Manson Brown, VP & Head of Clinical Development at Allerga...
|
Nov 01, 2023 |
|
Lead Investigator Dr. Genevieve Neal-Perry Discusses New Trial Data for Astellas’ Menopause Drug Fezolinetant (Veozah)
|
Oct 25, 2023 |
|
Johnson & Johnson Faces Lawsuit Over Patient Data Breach + Sleepiz’s Sleep Monitoring Device Gets FDA Clearance
|
Oct 18, 2023 |
|
Advancing CAR T Cell Therapies in Immuno-Oncology – Featuring Dr. Paul Rennert, CEO, CSO, Aleta Biotherapeutics
|
Oct 11, 2023 |
|
New HPV Vaccine Data Shows Long-Term Impact – Featuring Dr. Elmar Joura from the Medical University of Vienna
|
Oct 04, 2023 |
|
Interview with Dr. Kristin Yarema, President of Cell Therapy at Poseida Therapeutics
|
Sep 27, 2023 |
|
Advancements in Blood-Based Biomarker Tests for NASH — Interview with Dr. Tania Kamphaus and Tony Villiotti
|
Sep 20, 2023 |
|
Insights into New Alzheimer’s Treatments: Treating Agitation and First THC-Based Therapeutic in Trials — Interview with IGC’s Ram Mukunda and Claudia ...
|
Sep 13, 2023 |
|
Discussing Next Generation Chemotherapy Drugs with Processa Pharma’s Dr. David Young
|
Sep 06, 2023 |
|
More US States Take on Eli Lilly in Court Over Proposed Insulin Pricing Settlement + Regeneron’s High Dose Eylea Wins FDA Approval
|
Aug 30, 2023 |
|
Interview with BriaCell’s CEO Dr. William Williams
|
Aug 23, 2023 |
|
First Oral Tablet for Postpartum Depression + Court Rejects JJ’s Latest Bankruptcy Attempt
|
Aug 16, 2023 |
|
FDA Clearances for World’s Smallest Insulin Pump + New Cardiac Biomarker Test
|
Aug 09, 2023 |
|
In Conversation with Principal Investigator and SME Dr. Lawrence Eichenfield About the FDA Approval of a Drug-Device Combo for Common Skin Infection
|
Aug 02, 2023 |
|
Point-of-Care Testing for Infectious Diseases: Senzo CEO Jeremy Stackawitz Speaks About Company’s New Lateral Flow Technology
|
Jul 26, 2023 |
|
Biosimilars and the Problem with PBMs: Interview with Juliana M. Reed, Executive Director of the Biosimilars Forum
|
Jul 19, 2023 |
|
Opioid Use Disorder and Brixadi Approval: Interview with Dr. Joshua Cohen, Chief Medical Officer at Braeburn
|
Jul 12, 2023 |
|
Developing More Affordable Cellular Immunotherapies: Interview with CytoMed Therapeutics
|
Jul 05, 2023 |
|
Xtalks Speaks with Astellas Pharma’s VP & Head of BioPharma Development Marci English About Menopause Drug Approval
|
Jun 28, 2023 |
|
Wireless Charging for Medical Devices: Interview with Resonant Link’s CEO and Co-Founder Dr. Grayson Zulauf
|
Jun 21, 2023 |
|
In conversation with FNIH’s Dr. Courtney Silverthorn, Director of the AMP Bespoke Gene Therapy Consortium, About New Rare Disease Trial Portfolio
|
Jun 14, 2023 |
|
AI and ChatGPT for Medical Record Management: Interview with Carm Huntress, CEO and Founder of Credo Health
|
Jun 07, 2023 |
|
First Topical Gene Therapy + Bausch + Lomb’s First Prescription Med for Dry Eye
|
May 31, 2023 |
|
Veozah the New Drug for Menopausal Hot Flashes + SkinVive the New Dermal Filler
|
May 25, 2023 |
|
Interview with Dr. Gillian Woollett, VP, Head of Regulatory Strategy and Policy at Samsung Bioepis
|
May 17, 2023 |
|
World’s First RSV Vaccine + First Novel Treatment for ALS
|
May 10, 2023 |
|
Axonics’ Non-Drug Incontinence Therapy + How AI Can Be Used to Study the Side Effects of Drugs
|
May 03, 2023 |
|
Interview with Cody Simmons, CEO of DermaSensor, Maker of a Handheld Skin Cancer Evaluation Tool
|
Apr 26, 2023 |
|
EPA Proposes Stricter Ethylene Oxide Limits + Johnson and Johnson Offers $8.9 Billion Settlement
|
Apr 19, 2023 |
|
Interview with Wei-Li Shao, President Virtual Care Company Omada Health
|
Apr 12, 2023 |
|
Pharma By The Numbers: Celebrating 20 Years of Xtalks with an Analysis of the Industry
|
Apr 05, 2023 |
|
Interview with Definitive Healthcare’s VP, Head of Healthcare Consulting, Manu Garg, about Healthcare Commercial Intelligence
|
Mar 29, 2023 |
|
Interview with Tidepool’s CEO and Co-Founder Howard Look About an Automated Insulin Dosing App for Type 1 Diabetes
|
Mar 22, 2023 |
|
Interview with Neuromod COO Diarmuid Flavin About the FDA Approval of Tinnitus Treatment Lenire
|
Mar 15, 2023 |
|
FDA approval of First Geographic Atrophy Treatment and Authorization of First At-Home Combo COVID-19 and Flu Test
|
Mar 08, 2023 |
|
Interview with Cala Health’s CCO Doug Biehn about Neuromodulation Therapy Cala Trio for Hand Tremors
|
Mar 01, 2023 |
|
Sunrise’s At-Home Sleep Apnea Test Gets FDA Clearance + BMS-Pfizer Team up with Kareem Abdul Jabbar for AFib Awareness
|
Feb 22, 2023 |
|
Interview with Polarean Imaging CTO Dr. Bastiaan Driehuys on the FDA Approval of Lung Imaging Drug Device Combo Xenoview
|
Feb 15, 2023 |
|
Amgen Launches Humira Biosimilar Amjevita + Potential New Blood Test for Early Detection of Alzheimer’s
|
Feb 08, 2023 |
|
Amazon’s New $5 Prescription Drug Program + Top 10 Pharma TV Ad Spenders in 2022
|
Feb 01, 2023 |
|
Interview with Thea Pharma’s Susan Benton about Eye Care and the FDA Approval of Iyuzeh
|
Jan 25, 2023 |
|
XBB.1.5 Omicron Subvariant + FDA Approves AstraZeneca’s New Asthma Inhaler
|
Jan 18, 2023 |
|
Interview with Breast Surgical Oncologist Dr. Monique Gary on Cancer Health Disparities
|
Jan 11, 2023 |
|
Life Science Trends for 2023
|
Jan 04, 2023 |
|
Interview with the leaders at Amylyx, Maker of New FDA Approved ALS Drug Relyvrio
|
Dec 14, 2022 |
|
FDA Approves First Fecal Matter Therapy + PureTech Reveals New CBD Oral Capsule
|
Dec 07, 2022 |
|
First Gene Therapy Approved for Hemophilia B + World AMR Awareness Week
|
Nov 30, 2022 |
|
FDA Approves First Drug to Delay T1D + Positive Data for Pfizer’s Maternal RSV Vaccine
|
Nov 23, 2022 |
|
Novo Nordisk’s Ozempic (Semaglutide) Shortage and Fake Eli Lilly Twitter Account Announces Free Insulin
|
Nov 16, 2022 |
|
Interview with Eye Health Biotech Santen Pharmaceuticals’ CMO Peter Sallstig
|
Nov 09, 2022 |
|
FDA Approves Immunotherapies for Multiple Myeloma and Liver Cancer
|
Nov 02, 2022 |
|
Interview with Cystic Fibrosis and Rare Disease Patient Leader Gunnar Esiason
|
Oct 26, 2022 |
|
Elon Musk Reveals he Used Novo’s Wegovy for Weight Loss + FDA Approval of Nevro’s AI Spinal Cord Stimulation System
|
Oct 19, 2022 |
|
Bimodal Neuromodulation for Tinnitus: Interview with Caroline Hamilton, Clinical Director of Neuromod Devices – Xtalks Life Science Podcast Ep. 81
|
Oct 12, 2022 |
|
The Neurolenses Solution for Digital Vision Syndrome: Interview with Pierre Bertrand, CEO of Neurolens
|
Oct 05, 2022 |
|
FDA Approves World’s Most Expensive Gene Therapy for Rare Disease + CDC Concerned About New COVID-19 Variant
|
Sep 28, 2022 |
|
How Air Pollution Triggers Lung Cancer + Scientists Develop Parkinson’s Test Based on Woman’s Ability to Smell It
|
Sep 21, 2022 |
|
FDA Approval of Sanofi’s Enzyme Replacement Drug for ASMD + Disney Actress Partners with Medtronic for Diabetes Tech Campaign
|
Sep 14, 2022 |
|
Fitbit Introduces New Smartwatch with AFib Detection + FDA Approves Imbruvica for Pediatric Patients with cGVHD
|
Sep 07, 2022 |
|
FDA Approval of First Rapid-Acting Oral Depression Drug + Approval of $2.8 Million Gene Therapy for Rare Blood Disorder
|
Aug 31, 2022 |
|
Interview with Asaf Zviran, CEO of Cancer Genomics Company C2i Genomics
|
Aug 24, 2022 |
|
UK Approves First Omicron-Targeting COVID Vaccine + National Immunization Awareness Month
|
Aug 17, 2022 |
|
New COVID-19 Testing Technology + FDA Approves First Drug for HER2-Low Breast Cancer
|
Aug 10, 2022 |
|
FDA Approvals for Liquid Epilepsy Drug and a Vitiligo Medication
|
Aug 03, 2022 |
|
Towards a ’Functional Cure’ for Diabetes with Dr. Philip Toleikis, CEO, Sernova Corp
|
Jul 27, 2022 |
|
Expanded Approval for Gout Drug + Novavax COVID-19 Vaccine Gets FDA Authorization
|
Jul 20, 2022 |
|
FDA Issues Safety Warning for Blood Cancer Drug + Long COVID Risk Assessment Tool
|
Jul 13, 2022 |
|
BD Develops New Monkeypox Test + FDA Authorizes COVID-19 Vaccines for Infants
|
Jul 06, 2022 |
|
Eli Lilly’s Olumiant FDA Approved for Alopecia + Alnylam’s RNAi Drug Amvuttra Approved for Rare Protein Disorder
|
Jun 22, 2022 |
|
More Positive Data for Tirzepatide Weight Loss Injection + Sandoz’s Global Biosimilars Awareness Campaign
|
Jun 15, 2022 |
|
Interview with Georgia Tech’s Dr. Woon-Hong Yeo About a New Smart Stent Platform for Wireless Vascular Monitoring
|
Jun 08, 2022 |
|
Interview with Dr. Samantha Dale Strasser, CSO and Co-Founder of Transomics Drug Discovery Start-Up ”Pepper Bio”
|
Jun 01, 2022 |
|
FDA Approves New Type 2 Diabetes Injection Mounjaro + US Reports First Case of Monkeypox
|
May 25, 2022 |
|
Messaging Program Improves Lifestyle Among Heart Attack Survivors + FDA Places Stricter Restrictions on Janssen COVID-19 Vaccine
|
May 18, 2022 |
|
FDA Approves Bristol Myers’ Cardiac Drug for HCM + New Ovarian Cancer Blood Test
|
May 11, 2022 |
|
First FDA-Approved Treatment for Chronic Yeast Infection + Eli Lilly Obesity Drug Shows Promise in Trials
|
May 04, 2022 |
|
World Immunization Week 2022 + New COVID-19 Breath Test Gets FDA Authorization
|
Apr 27, 2022 |
|
BioNTech Partners for mRNA Vaccine Delivery Tech + Pfizer Acquires ReViral for RSV Therapeutics
|
Apr 20, 2022 |
|
Statins May Lower Parkinsonism Risk + New Genetic Test to Prevent Deafness in Babies
|
Apr 13, 2022 |
|
Clinical Trial Diversity Insights from NIH Experts + WHO and Polluted Air on World Health Day 2022
|
Apr 06, 2022 |
|
Pfizer Recalls Blood Pressure Medication + Jazz Pharma Manufacturing Cannabis-Based Medications
|
Mar 30, 2022 |
|
Exact Sciences and Katie Couric’s Colon Cancer Awareness TV Ad + Alnylam Sues Pfizer and Moderna Over Patent Infringements
|
Mar 23, 2022 |
|
Johnson & Johnson Funding Human Asbestos Studies + Swift Medical’s Imaging Device for Remote Digital Wound Care
|
Mar 16, 2022 |
|
Celebrating Women’s Leadership in Life Sciences on International Women’s Day + Johnson & Johnson’s Cell Therapy for Multiple Myeloma Gets FDA Approval
|
Mar 09, 2022 |
|
Marking Rare Disease Day 2022 by Sharing Colours + Why Black People Remain Underrepresented in Clinical Trials
|
Mar 02, 2022 |
|
BioNTech Unveils Modular mRNA Factories for Africa + FDA Authorizes Eli Lilly Monoclonal Antibody Effective Against Omicron
|
Feb 23, 2022 |
|
UK’s NHS Backs World’s Costliest Drug for Treatment of MLD + Report Finds Increase in Pharma Cybersecurity Threats
|
Feb 16, 2022 |
|
Inbody’s At-Home Real Time Blood Pressure Monitoring + Eli Lilly Announces Investments into New Manufacturing Facilities
|
Feb 09, 2022 |
|
FDA Approval for First TCR Therapy for Uveal Melanoma + Pfizer and Moderna Begin Trials for Omicron Booster
|
Feb 02, 2022 |
|
Gilead Sues Over Counterfeit HIV Drugs + Menarini’s New Rapid COVID-19 PCR Test
|
Jan 26, 2022 |
|
Study Shows Exercise Can Maintain Cognitive Health in Elderly + Abbott’s New Cardiac Mapping System
|
Jan 19, 2022 |
|
New Cancer Blood Test + Bayer Commits to All Green Packaging by 2030
|
Jan 12, 2022 |
|
FDA and CDC Update Guidelines Amid Omicron + Life Science Trends for 2022
|
Jan 05, 2022 |
|
Biohaven Intranasal Migraine Drug Gets FDA Approval + Moderna’s mRNA Influenza Vaccine
|
Dec 15, 2021 |
|
Moderna and Pfizer Premature Statements on Omicron + FDA Approves New Hepatitis B Vaccine
|
Dec 08, 2021 |
|
WHO Declares Omicron Variant of Concern + Seizure Drug Recalled Over Faulty Seal
|
Dec 01, 2021 |
|
Virtual Reality Treatment for Chronic Pain + Canadian CDMO Biovectra to Build mRNA Manufacturing Plant
|
Nov 24, 2021 |
|
Xtalks Voices: Magnus Medical CEO Dr. Brett Wingeier Talks About Neurostimulation for Depression
|
Nov 17, 2021 |
|
Pfizer’s COVID-19 Antiviral Pill + FDA Approves AbbVie’s Eyedrop for Presbyopia
|
Nov 10, 2021 |
|
FDA Authorizes Pfizer COVID-19 Vaccine for Children 5 to 11 + Genentech’s Drug Delivery System for Macular Degeneration
|
Nov 03, 2021 |
|
FDA Approves Interchangeable Humira Biosimilar + Gene Silencing Treatment for Porphyria Gets Nod From England’s NICE
|
Oct 27, 2021 |
|
Moderna Unwilling to Share COVID-19 Recipe + Singer Mary J Blige Partners with Hologic for Breast Cancer Awareness
|
Oct 20, 2021 |
|
Researchers Develop Arthritis Vaccine + Medtronic Expands Recall on Insulin Pumps
|
Oct 13, 2021 |
|
CDC Says Flu and COVID-19 Shots Can Be Co-Administered + Merck’s Oral Antiviral for COVID-19 Shows Stellar Results
|
Oct 06, 2021 |
|
New FDA ”Bad Ad” Quiz + Pfizer COVID-19 Vaccine Data for Young Children
|
Sep 29, 2021 |
|
FDA on COVID-19 Vaccine Boosters + Advocacy Group Pushes for Speedy FDA Approval of ALS Drug
|
Sep 22, 2021 |
|
Eli Lilly to Develop RNA Editing Therapies + Study Shows Benefits of Daily Steps
|
Sep 15, 2021 |
|
World’s First Smart Knee + Alzheimer’s Blood Test
|
Sep 08, 2021 |
|
Why Antimicrobial Resistance is a Silent Pandemic
|
Sep 01, 2021 |
|
How the Approval of Aducanumab Will Change Alzheimer’s Trials
|
Aug 25, 2021 |
|
FDA Authorizes COVID-19 Vaccine Boosters for Immunocompromised Individuals
|
Aug 18, 2021 |
|
AAIC 2021 – COVID-19 Impacts on Cognitive Health + Pancreatic Cancer Blood Test
|
Aug 11, 2021 |
|
AAIC 2021 - Diversity in Clinical Trials + Johnson & Johnson Sued by Black Women’s Group
|
Aug 04, 2021 |
|
AAIC 2021 – Aduhelm Recommendations + Pfizer’s Expanded Chantix Recall
|
Jul 28, 2021 |
|
WHO Comments on COVID-19 Vaccine Mixing + World’s First Glucose Saliva Test
|
Jul 21, 2021 |
|
Nestlé to Market Oral Microbiome Drug for C. Difficile + WHO Recommends IL-6 Blockers as Life-Saving COVID-19 Treatment
|
Jul 14, 2021 |
|
First FDA-Approved Video Game for ADHD + Why Not to Worry About Menstrual Changes After COVID-19 Vaccination
|
Jul 07, 2021 |
|
NeuraLace’s Peripheral Nerve Stimulation System for Chronic Pain + AstraZeneca Fights COVID Vaccine Delivery Lawsuit
|
Jun 30, 2021 |
|
Measuring Body Fat Percentage with Amazon’s Halo app + Regeneron’s Antibody Treatment Cuts Risk of COVID-19 Deaths
|
Jun 23, 2021 |
|
World’s First Digital Fabric + Amazon’s Direct-to-Consumer COVID-19 Test
|
Jun 16, 2021 |
|
Fruit and Type 2 Diabetes Risk + Moderna’s Manufacturing Partnerships
|
Jun 09, 2021 |
|
Google’s AI Dermatology App + WHO’s Investigations into the Coronavirus Lab Leak Theory
|
Jun 02, 2021 |
|
Clinical Trials Day 2021 + AbbVie’s Humira Monopoly
|
May 26, 2021 |
|
Pharma TV Ad Spending Trends + AI Algorithm for Heart Disease
|
May 19, 2021 |
|
Epigenetic Editing with CRISPR + ADHD in Preschoolers
|
May 12, 2021 |
|
At-Home Sleep Apnea Test + Neurological Rehabilitation Device for Stroke Patients
|
May 05, 2021 |
|
Malaria Vaccine + Sugar’s Effect on Brain Development in Children
|
Apr 28, 2021 |
|
J&J COVID-19 Vaccine and Thrombosis + Medtronic’s Harmony Transcatheter Pulmonary Valve Approval
|
Apr 21, 2021 |
|
Parkinson’s Disease: Link With Melanoma + Drug Development
|
Apr 14, 2021 |
|
Social Media’s Disinformation Dozen + Pfizer’s Latest COVID-19 Vaccine Trial Results
|
Apr 07, 2021 |
|
Caffeine Consumption in Pregnancy + Portable Neuromodulation Stimulator for MS
|
Mar 31, 2021 |
|
Mask-Associated Dry Eye + Droplet Micron Insulin Needle
|
Mar 24, 2021 |
|
Why You Can’t Compare COVID-19 Vaccine Efficacies
|
Mar 24, 2021 |
|
COVID-19 Pandemic Anniversary + Cancer Biotech Acquisitions
|
Mar 24, 2021 |